Literature DB >> 20655305

Cytoprotective effects of the volatile anesthetic sevoflurane are highly dependent on timing and duration of sevoflurane conditioning: findings from a human, in-vitro hypoxia model.

Karina Zitta1, Patrick Meybohm, Berthold Bein, Henning Ohnesorge, Markus Steinfath, Jens Scholz, Martin Albrecht.   

Abstract

Using animal models, volatile anesthetics have been recognized for their neuroprotective effects. Nevertheless, there is still disagreement about the optimal duration and timing of conditioning with the volatile anesthetic sevoflurane in the human system. In the study presented, we employed a human neuronal cell culture model to investigate the effects of hypoxia and to evaluate potential cytoprotective properties of different sevoflurane conditioning strategies. Sevoflurane was applied to human IMR-32 cells in which hypoxic conditions were induced for 2h using our recently described two-enzyme model (Zitta et al., Eur. J. Pharmacol., 2010). Cellular effects of hypoxia and sevoflurane conditioning were evaluated by lactate dehydrogenase (LDH) measurements, brightfield microscopy, ELISAs, cytometric bead arrays, Westernblotting and RT-PCR. Hypoxia increased the release of LDH into the culture medium after 24h (normoxia: 0.15+/-0.02 a.u; hypoxia: 0.69+/-0.08 a.u, P<0.001) and expression of hypoxia associated genes HIF-1alpha, VEGF, catalase. Cytoprotective effects were observed in cultures that received sevoflurane for 30 min before hypoxia (preconditioning: 0.41+/-0.07 a.u., P<0.01) and for 30 min during the hypoxic period (intraconditioning: 0.20+/-0.01 a.u., P<0.001). Application of sevoflurane after the hypoxic insult did not lead to cytoprotection (postconditioning: 0.73+/-0.12a.u., P>0.05). Conditioning with sevoflurane for a total of 3h before, during and after hypoxia, however, resulted in an enhanced release of LDH (periconditioning: 0.97+/-0.10a.u., P<0.01) and additional cell damage. Hypoxia and sevoflurane intraconditioning were associated with changes in erk1/2 phosphorylation (T202/Y204) and HIF-1alpha protein levels, whereas phosphorylation of akt (S473) was not significantly altered. Our results suggest short pre- and intraconditioning with sevoflurane as most potent strategies to reduce hypoxia induced neuronal cell damage.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20655305     DOI: 10.1016/j.ejphar.2010.07.017

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

1.  Serum from patients undergoing remote ischemic preconditioning protects cultured human intestinal cells from hypoxia-induced damage: involvement of matrixmetalloproteinase-2 and -9.

Authors:  Karina Zitta; Patrick Meybohm; Berthold Bein; Christin Heinrich; Jochen Renner; Jochen Cremer; Markus Steinfath; Jens Scholz; Martin Albrecht
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

2.  Re: "Gene expression analysis to identify molecular correlates of pre- and post-conditioning derived neuroprotection". Letter to the editor.

Authors:  Karina Zitta; Berthold Bein; Martin Albrecht
Journal:  J Mol Neurosci       Date:  2012-12-25       Impact factor: 3.444

3.  Isoflurane preconditioning protects astrocytes from oxygen and glucose deprivation independent of innate cell sex.

Authors:  Dustin Johnsen; Stephanie J Murphy
Journal:  J Neurosurg Anesthesiol       Date:  2011-10       Impact factor: 3.956

4.  The effect of sevoflurane postconditioning on cardioprotection against ischemia-reperfusion injury in rabbits.

Authors:  Dong Chen; Bo Cheng; Hai-Yan Zhou; Li-Huan Li
Journal:  Mol Biol Rep       Date:  2012-01-07       Impact factor: 2.316

Review 5.  General anesthesia bullies the gut: a toxic relationship with dysbiosis and cognitive dysfunction.

Authors:  Lidan Liu; Lihua Shang; Dongxue Jin; Xiuying Wu; Bo Long
Journal:  Psychopharmacology (Berl)       Date:  2022-02-21       Impact factor: 4.530

6.  miR-15b suppression of Bcl-2 contributes to cerebral ischemic injury and is reversed by sevoflurane preconditioning.

Authors:  Hong Shi; Bao-liang Sun; Jia Zhang; Shiduo Lu; Pengyue Zhang; Hailian Wang; Qiong Yu; R Anne Stetler; Peter S Vosler; Jun Chen; Yanqin Gao
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

7.  Investigation of tumor hypoxia using a two-enzyme system for in vitro generation of oxygen deficiency.

Authors:  Vasileios Askoxylakis; Gunda Millonig; Ute Wirkner; Christian Schwager; Shoaib Rana; Annette Altmann; Uwe Haberkorn; Jürgen Debus; Sebastian Mueller; Peter E Huber
Journal:  Radiat Oncol       Date:  2011-04-10       Impact factor: 3.481

8.  Do different anesthesia regimes affect hippocampal apoptosis and neurologic deficits in a rodent cardiac arrest model?

Authors:  Stepani Bendel; Dirk Springe; Adriano Pereira; Denis Grandgirard; Stephen L Leib; Alessandro Putzu; Jannis Schlickeiser; Stephan M Jakob; Jukka Takala; Matthias Haenggi
Journal:  BMC Anesthesiol       Date:  2015-01-15       Impact factor: 2.217

9.  Effects of sevoflurane postconditioning on cell death, inflammation and TLR expression in human endothelial cells exposed to LPS.

Authors:  Raquel Rodríguez-González; Aurora Baluja; Sonia Veiras Del Río; Alfonso Rodríguez; Jaime Rodríguez; Manuel Taboada; David Brea; Julián Álvarez
Journal:  J Transl Med       Date:  2013-04-03       Impact factor: 5.531

10.  An insert-based enzymatic cell culture system to rapidly and reversibly induce hypoxia: investigations of hypoxia-induced cell damage, protein expression and phosphorylation in neuronal IMR-32 cells.

Authors:  Ying Huang; Karina Zitta; Berthold Bein; Markus Steinfath; Martin Albrecht
Journal:  Dis Model Mech       Date:  2013-09-05       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.